newsfilter
← Latest News
Business Wire·

Syros Reports Third Quarter 2023 Financial Results and Provides a Corporate Update

– On track to report initial data from approximately 20 patients in SELECT-AML-1 trial in early December 2023 – – Expect to report pivotal CR data from SELECT-MDS-1 by mid-4Q 2024 – – Founding CEO, Nancy Simonian,